PRTC
Income statement / Annual
Last year (2024), PureTech Health plc's total revenue was $4.83 M,
an increase of 44.98% from the previous year.
In 2024, PureTech Health plc's net income was $53.51 M.
See PureTech Health plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$4.83 M |
$3.33 M |
$2.09 M |
$9.98 M |
$8.34 M |
$8.69 M |
$16.37 M |
$650.00 K |
$4.43 M |
$11.74 M |
| Cost of Revenue |
$0.00
|
$4.93 M
|
$152.43 M
|
$110.47 M
|
$0.00
|
$85.85 M
|
$77.40 M
|
$71.04 M
|
$1.57 M
|
$740.00 K
|
| Gross Profit |
$1.26 M
|
-$1.60 M
|
-$136.82 M
|
-$100.49 M
|
$8.34 M
|
-$77.16 M
|
-$61.03 M
|
-$70.39 M
|
$2.86 M
|
$11.00 M
|
| Gross Profit Ratio |
0.26
|
-0.48
|
-65.46
|
-10.07
|
1
|
-8.88
|
-3.73
|
-108.28
|
0.65
|
0.94
|
| Research and Development Expenses |
$54.28 M
|
$96.24 M
|
$116.11 M
|
$81.52 M
|
$61.19 M
|
$65.17 M
|
$57.29 M
|
$71.67 M
|
$41.21 M
|
$13.41 M
|
| General & Administrative Expenses |
$27.49 M
|
$25.18 M
|
$35.67 M
|
$30.76 M
|
$26.50 M
|
$34.89 M
|
$24.43 M
|
$46.28 M
|
$37.16 M
|
$18.38 M
|
| Selling & Marketing Expenses |
$0.00
|
$23.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$27.49 M
|
$48.36 M
|
$35.67 M
|
$30.76 M
|
$26.50 M
|
$34.89 M
|
$24.43 M
|
$46.28 M
|
$37.16 M
|
$18.38 M
|
| Other Expenses |
$58.64 M
|
-$90.04 M
|
-$90.79 M
|
$47.98 M
|
$40.19 M
|
$44.03 M
|
-$278.00 K
|
$14.00 K
|
$46.00 K
|
$448.00 K
|
| Operating Expenses |
$140.41 M
|
$54.55 M
|
$60.99 M
|
$160.26 M
|
$127.87 M
|
$144.09 M
|
$120.39 M
|
$116.07 M
|
$78.36 M
|
$55.38 M
|
| Cost And Expenses |
$140.41 M
|
$149.53 M
|
$213.43 M
|
$167.67 M
|
$127.87 M
|
$144.09 M
|
$120.39 M
|
$116.07 M
|
$78.36 M
|
$55.38 M
|
| Interest Income |
$22.67 M
|
$16.01 M
|
$5.80 M
|
$214.00 K
|
$1.18 M
|
$4.36 M
|
$3.36 M
|
$1.75 M
|
$1.19 M
|
$262.00 K
|
| Interest Expense |
$10.04 M
|
$13.49 M
|
$3.95 M
|
$4.71 M
|
$2.95 M
|
$4.10 M
|
$14.81 M
|
$10.21 M
|
$6.81 M
|
$4.35 M
|
| Depreciation & Amortization |
$3.57 M
|
$4.93 M
|
$8.89 M
|
$7.24 M
|
$6.66 M
|
$6.67 M
|
$2.78 M
|
$2.10 M
|
$1.57 M
|
$740.00 K
|
| EBITDA |
$37.38 M |
-$11.63 M |
-$188.91 M |
$26.70 M |
$62.69 M |
$487.78 M |
-$65.27 M |
-$40.79 M |
-$74.80 M |
-$51.23 M |
| EBITDA Ratio |
7.74
|
-3.49
|
-90.39
|
2.68
|
7.52
|
56.14
|
-3.99
|
-62.76
|
-16.88
|
-4.36
|
| Operating Income Ratio |
-28.19
|
-43.9
|
-94.64
|
-15.06
|
-14.33
|
-15.58
|
-6.35
|
-177.57
|
-16.68
|
-3.72
|
| Total Other Income/Expenses Net |
$159.87 M
|
$110.10 M
|
$105.02 M
|
$91.33 M
|
$138.50 M
|
$613.87 M
|
$35.58 M
|
$44.71 M
|
-$9.25 M
|
-$12.68 M
|
| Income Before Tax |
$23.77 M
|
-$36.10 M
|
-$92.78 M
|
-$58.95 M
|
$18.97 M
|
$478.47 M
|
-$68.44 M
|
-$70.71 M
|
-$83.18 M
|
-$56.32 M
|
| Income Before Tax Ratio |
4.92
|
-10.84
|
-44.39
|
-5.91
|
2.27
|
55.07
|
-4.18
|
-108.79
|
-18.77
|
-4.8
|
| Income Tax Expense |
-$4.01 M
|
$30.53 M
|
-$55.72 M
|
$3.76 M
|
$14.40 M
|
$112.41 M
|
$2.22 M
|
-$14.00 K
|
-$1.57 M
|
$1.92 M
|
| Net Income |
$53.51 M
|
-$65.70 M
|
-$50.36 M
|
-$60.56 M
|
$5.99 M
|
$421.14 M
|
-$43.65 M
|
$30.87 M
|
-$48.79 M
|
-$39.39 M
|
| Net Income Ratio |
11.08
|
-19.73
|
-24.09
|
-6.07
|
0.72
|
48.47
|
-2.67
|
47.49
|
-11.01
|
-3.36
|
| EPS |
2 |
-2.4 |
-1.8 |
-2.1 |
0.2 |
14.9 |
-1.6 |
1.1 |
-2.1 |
-2.1 |
| EPS Diluted |
2 |
-2.4 |
-1.8 |
-2.1 |
0.2 |
14.4 |
-1.6 |
1.1 |
-2.1 |
-2.1 |
| Weighted Average Shares Out |
$26.97 M
|
$27.63 M
|
$27.97 M
|
$28.66 M
|
$29.93 M
|
$29.25 M
|
$27.28 M
|
$24.07 M
|
$22.95 M
|
$18.53 M
|
| Weighted Average Shares Out Diluted |
$26.97 M
|
$27.63 M
|
$28.48 M
|
$28.66 M
|
$29.29 M
|
$29.18 M
|
$27.38 M
|
$23.89 M
|
$22.95 M
|
$18.53 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
